Skip to Content

Posts tagged with "Who Discovers and Why"

  • Business and Markets

    Drug Discovery in India

    Molecular biologist Swapnika Ramu, a reader from India, sends along a worthwhile (and tough) question. She says that after her PhD (done in the US), her return to India has made her “less than optimistic” about the current state of drug discovery there. (Links in the below quote have been added by me, not her: Read More
  • Who Discovers and Why

    NIH Taking on More RIsk?

    You’d have to think that this is at least a step in the right direction: “NIH to experiment with high-risk grants”: On 5 December, agency director Francis Collins told an advisory committee that the NIH should consider supporting more individual researchers, as opposed to research proposals as it does now — an idea inspired in… Read More
  • In Silico

    Standards of Proof

    Here are some slides from Anthony Nicholls of OpenEye, from his recent presentation here in Cambridge on his problems with molecular dynamics calcuations. Here’s his cri du coeur (note: fixed a French typo from the original post there): . . .as a technique MD has many attractive attributes that have nothing to do with its… Read More
  • Who Discovers and Why

    Organizing Research

    Here’s an article in Angewandte Chemie that could probably have been published in several other places, since it’s not specifically about chemistry. It’s titled “The Organization of Innovation – The History of an Obsession”, from Caspar Hirschi at St. Gallen in Switzerland, and it’s a look at how both indus… Read More
  • Who Discovers and Why

    Creativity Training For Creative Creators

    Here’s a bilous broadside against the whole “creativity” business – the books, courses, and workshops that will tell you how to unleash the creative powers within your innards and those of your company: And yet the troubled writer also knew that there had been, over these same years, fantastic growth in our creativity promot… Read More
  • Who Discovers and Why

    An Inspirational Quote from Bernard Munos

    In the comments thread to this post, Munos has this to say: Innovation cannot thrive upon law and order. Sooner or later, HR folks will need to come to grips with this. Innovators (the real ones) are rebels at heart. They are not interested in growing and nurturing existing markets beccause they want to obliterate… Read More
  • Drug Industry History

    Reworking Big Pharma

    Bruce Booth (of Atlas Venture Capital) has a provocative post up at Forbes on what he would do if he were the R&D head of a big drug company. He runs up his flag pretty quickly: I don’t believe that we will cure the Pharma industry of its productivity ills through smarter “operational excellence” approaches. Read More
  • Business and Markets

    The GSK Jackpot

    Well, this got my attention: according to the Sunday Times, GlaxoSmithKline is preparing to hand out hefty bonus payments to scientists if they have a compound approved for sale. Hefty, in this context, means up to several million dollars. The earlier (and much smaller) payouts for milestones along the way will disappear, apparently, to be… Read More
  • Current Events

    One. . .Million. . .Pounds (For a New Antibiotic?)

    Via Stuart Cantrill on Twitter, I see that UK Prime Minister David Cameron is prepared to announce a prize for anyone who can “identify and solve the biggest problem of our time”. He’s leaving that open, and his examples are apparently “. . .the next penicillin, aeroplane or world wide web”. I like the idea… Read More
  • Book Recommendations

    E. O. Wilson’s “Letters to a Young Scientist”

    I’ve been reading E. O. Wilson’s new book, Letters to a Young Scientist. It’s the latest addition to the list of “advice from older famous scientists” books, which also includes Peter Medawar’s similarly titled Advice To A Young Scientist and what is probably the grandfather of the entire genre, Ramón y Cajal… Read More